Navigation Links
Chewing gum -- the new post-operative medicine

In an article recently recommended by Bradley Kropp of Faculty of 1000 Medicine, researchers find chewing gum is a simple solution to the recovery of bowel function after gastrointestinal surgery a problem that has troubled patients and physicians for decades.

Authors of the paper published in Urology evaluated 102 patients undergoing gastrointestinal surgery and gave half of them 5 pieces of chewing gum per day after their operation. Chewing the gum is thought to stimulate the smooth muscle fibers and secretion from the salivary glands and liver. The 51 patients who chewed gum recovered their bowel movement significantly faster than those who did not.

Pediatric Urologist, Kropp will be giving his patients undergoing reconstructive surgery a piece of gum following their operation. He says, In todays high-tech, molecular-driven scientific world, it is nice to come across an article that can be implemented immediately into our practices without increased healthcare cost

Kropp also adds, Just think how much a pack of gum would cost today had the pharmaceutical industry come across this information first


Contact: Jemima Tonks
BioMed Central

Page: 1

Related medicine news :

1. Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance
2. Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
3. UI nursing researcher to study post-operative pain control
4. Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks
5. Reproductive Medicine Associates of Texas Announces Open House in San Antonio
6. FSU College of Medicine researcher seeks to uncover new cancer therapies
7. International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as its First and Only Official Joint and Muscle Topical Cream
8. Former Biolase CEO & EVP Launch Technology4Medicine
9. News Briefs from Preventive Medicine 2008
10. Combination of Thyroid Medicines Not Necessary
11. Springer to launch new journal in emergency medicine
Post Your Comments:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: